On Patient Wolf Gin's official history page, Patient Wolf Gin is mentioned 0 times. The brand tells a story of Australian origin while the corporate reality is carefully omitted.
Patient Wolf was founded in 2015 by Dave Irwin and Matt Argus in Melbourne, Victoria. The name references the patience required in craft distilling — good things come to those who wait, apparently. They started with a custom-built copper pot still named 'Kylie' and focused on creating gins using native Australian botanicals. The distillery quickly gained recognition, winning multiple awards including World's Best Contemporary Gin at the World Gin Awards. Unlike many 'craft' brands that get snapped up by multinationals the moment they gain traction, Patient Wolf has remained stubbornly independent.
No deception tactics identified. Patient Wolf is transparent about being a Melbourne-based independent operation. Their marketing accurately reflects their ownership structure, and they don't trade on false heritage narratives or hide behind corporate shells.
Profits remain in Australia with the independent founders and local investors. Your gin money stays in Melbourne, supporting local jobs at their Southbank distillery. No offshore dividend extraction to foreign shareholders.
Buying Patient Wolf supports genuine Australian craft manufacturing, local employment, and independent business ownership. Premium pricing reflects actual small-batch production costs rather than multinational marketing budgets.
If you're exploring Australian independent gins: Four Pillars (Yarra Valley, though note they have external investment), Adelaide Hills Distillery (South Australia), and Never Never Distilling Co. (McLaren Vale) are comparable quality independents.